Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study, Diabetes, vol.52, pp.2490-2496, 2003. ,
Insulin resistance, insulin response, and obesity as indicators of metabolic risk, Journal of Clinical Endocrinology and Metabolism, vol.92, pp.2885-92, 2007. ,
HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus, Curr Opin Lipidol, vol.21, pp.178-85, 2010. ,
Components of metabolic syndrome and 5-year change in insulin clearance-the Insulin Resistance Atherosclerosis Study, Diabetes, obesity & metabolism, vol.15, pp.441-448, 2013. ,
Effects of highdensity lipoproteins on pancreatic beta-cell insulin secretion, Arterioscler Thromb Vasc Biol, vol.30, pp.1642-1650, 2010. ,
Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells, Diabetologia, vol.50, pp.1304-1318, 2007. ,
Highdensity lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus, Circulation, vol.119, pp.2103-2114, 2009. ,
Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid A ,
, Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial, Circulation, vol.124, pp.555-62, 2011.
Using Genetic Variants to Assess the Relationship Between Circulating Lipids and Type 2 Diabetes, Diabetes, vol.64, pp.2676-84, 2015. ,
NADPH oxidase 2 plays a critical role in dysfunction and apoptosis of pancreatic beta-cells induced by very low-density lipoprotein, Mol Cell Biochem, vol.370, pp.103-116, 2012. ,
Blood lipids affect rat islet blood flow regulation through beta(3)-adrenoceptors, Am J Physiol Endocrinol Metab, vol.307, pp.653-63, 2014. ,
Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release, Endocrinology, vol.133, pp.208-222, 1993. ,
, Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat, J Clin Invest, vol.97, pp.2728-2763, 1996.
A 48-hour lipid infusion in the rat time-dependently inhibits glucoseinduced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation, Endocrinology, vol.127, pp.1580-1589, 1990. ,
Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats, Diabetes, vol.48, pp.524-554, 1999. ,
Influence of endogenous NEFA on beta cell function in humans, Diabetologia, vol.58, pp.2344-52, 2015. ,
Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes, Diabetes, vol.49, pp.399-408, 2000. ,
, A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes, Diabetes, vol.52, pp.2461-74, 2003.
The ingestion of saturated fatty acid triacylglycerols acutely affects insulin secretion and insulin sensitivity in human subjects, The British journal of nutrition, vol.92, pp.895-903, 2004. ,
Hepatic insulin clearance is closely related to metabolic syndrome components, Diabetes Care, vol.36, pp.3779-85, 2013. ,
Effect of liver fat on insulin clearance, American journal of physiology Endocrinology and metabolism, vol.293, pp.1709-1724, 2007. ,
Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction, Diabetes, vol.56, pp.2328-2366, 2007. ,
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials, Lancet, vol.375, pp.735-777, 2010. ,
Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort, Diabetologia, vol.58, pp.1109-1126, 2015. ,
The EGIR-RISC Study (the European group for the study of insulin resistance: Relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and Objectives, Diabetologia, vol.47, pp.566-70, 2004. ,
Meal and oral glucose tests for the assessment of ß-cell function: modeling analysis in normal subjects ,
, Am J Physiol Endocrinol Metab, vol.283, pp.1159-66, 2002.
Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for Cpeptide clearance, Diabetes, vol.41, pp.368-77, 1992. ,
Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment, Nature medicine, vol.13, pp.340-347, 2007. ,
Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice ,
, Diabetologia, vol.53, pp.1110-1119, 2010.
Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus, JAMA, vol.313, pp.1029-1065, 2015. ,
The effect of rosuvastatin on insulin sensitivity and pancreatic beta-cell function in nondiabetic renal transplant recipients, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol.9, p.1439, 2009. ,
, Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes, Diabetes, vol.51, pp.2596-603, 2002.
, Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells, PLoS One, vol.10, p.142902, 2015.
Characterization of ?-cell function impairment in first-degree relatives of type 2 diabetic subjects: Modeling analysis of 24-h triple-meal tests, American Journal of Physiology-Endocrinology and Metabolism, vol.288, 2005. ,
Effects of high-density lipoprotein elevation with cholesteryl ester transfer protein inhibition on insulin secretion, Circ Res, vol.113, pp.167-75, 2013. ,
Loss-offunction mutations in ABCA1 and enhanced beta-cell secretory capacity in young adults, Diabetes, vol.64, pp.193-202, 2015. ,
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids, J Biol Chem, vol.278, pp.11303-11314, 2003. ,
Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men, Atherosclerosis, vol.240, pp.272-279, 2015. ,
, Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease, Circulation, vol.109, pp.2197-202, 2004.
Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes, Atherosclerosis, vol.194, pp.265-71, 2007. ,
Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes, Diabetologia, vol.56, pp.423-456, 2013. ,
Diabetic dyslipidaemia. Current opinion in lipidology, vol.17, pp.238-284, 2006. ,